Business
from24/7 Wall St.
2 days agoNovo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Sept 2025)
Novo Nordisk's GLP-1 weight-loss drugs have generated massive sales, transforming the company into a global pharmaceutical powerhouse while expanding obesity and diabetes treatment pipelines.